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Véronique Jestin3, Peter Lind4 and Poul H Jørgensen1
Abstract
Background: Avian influenza virus (AIV) subtypes H5 and H7 attracts particular attention because of the risk of their
potential pathogenicity in poultry. The haemagglutination inhibition (HI) test is widely used as subtype specific test
for serological diagnostics despite the laborious nature of this method. However, enzyme-linked immunosorbent
assays (ELISAs) are being explored as an alternative test method.
H5 and H7 specific monoclonal antibodies were experimentally raised and used in the development of inhibition
ELISAs for detection of serological response specifically directed against AIV subtypes H5 and H7. The ELISAs were
evaluated with polyclonal chicken anti-AIV antibodies against AIV subtypes: H1N2, H5N2, H5N7, H7N1, H7N7, H9N9,
H10N4 and H16N3.
Results: Both the H5 and H7 ELISA proved to have a high sensitivity and specificity and the ELISAs detected H5
and H7 antibodies earlier during experimental infection than the HI test did. The reproducibility of the ELISA’s
performed at different times was high with Pearson correlation coefficients of 0.96-0.98.
Conclusions: The ELISAs are a potential alternative to the HI test for screening of large amounts of avian sera,
although only experimental sera were tested in this study.
Keywords: Avian influenza, Monoclonal antibody, Inhibition ELISA, H5, H7, Serology, Haemagglutination inhibition
test, Experimental sera
Background
Avian influenza is an emerging global challenge regard-
ing the potential for pandemics with severe impact on
the avian health and economy, reviewed by [1]. Of spe-
cial concern is the avian influenza virus (AIV) subtype
H5 and H7, which have potentials to become highly
pathogenic avian influenza (HPAI) [2]. The zoonotic
potential of H5 and H7 infections [3,4] and the severe
impact of HPAI infections for the poultry industry [5]
emphasise the need for sensitive and effective diag-
nostic methods and surveillances to early detect low
pathogenic avian influenza infections. For this purpose,
many national serological surveillance programmes rely
on the use of haemagglutination inhibition (HI) test [6].
However, for screening of high numbers of samples the
enzyme-linked immunosorbent assay (ELISA) techniques
are superior in throughput, speed and less independent of
many different antigen cultures which are needed for the
HI test. Several ELISAs for detection of antibodies against
the AIV nucleoprotein (NP) using inactivated NP antigen
[7,8], recombinant proteins [9-13] and antigens expressed
in yeast [14] have been described. These ELISAs have
been tested with field sera and sera from experimentally
inoculated birds of a number of different avian species in-
cluding chicken [7-9,11-13,15], turkey [9,13], emu [9,13],
ostrich [8,9,13] and duck [7,8,10]. Additionally, com-
mercially available kits for AIV antibody detection have
been compared to the HI test and agar gel immodiffusion
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(AGID) test [16-20]. These kits had higher sensitivity
compared to the AGID when testing duck and wild bird
sera [16,19,21]. One kit had higher sensitivity compared to
HI test of a number of poultry species including duck
[17], while another kit had no higher sensitivity testing do-
mestic duck sera in comparison with the HI test [19].
ELISAs targeting H7 antibodies by use of inactivated
H7 antigen [22], partially purified H7N1 antigen [23] or
purified recombinant H7 protein [24] have been pub-
lished. The use of recombinant protein for coating the
ELISA plates may avoid steric interference by the neur-
aminidase protein (N) [24,25]. Inactivated whole antigen
is practically applicable although it can cause problems
most likely related to interference with the N protein
[24]. ELISA employing a H5 monoclonal antibody (mAb)
and purified H5N2 virus as coating antigen has so far been
described for detection of H5 antibodies in chickens
during an outbreak of A/chicken/Taiwan/1209/03(H5N2)
[26] and for wild aquatic birds in Italy [27]. Two pro-
mising studies of H5 ELISA also using H5 mAb was
recently described for testing of chickens, turkeys and
ducks [25,28].
The continuing circulation and threat of subtypes H5
and H7 AIV (reviewed in [29]) sustain an increasing
demand for diagnostic tools to detect antibodies spe-
cifically against these AIV subtypes. Consequently, we
developed H5 and H7 mAbs for use in ELISA and im-
munocytochemistry. These H5 and H7 mAbs were ap-
plied in inhibition ELISAs and evaluated with antibodies
raised experimentally in SPF chickens against a number
of different AIV subtypes: H1N2, H5N2, H5N7, H7N1,
H7N7, H9N9, H10N4, H16N3. The mAbs recognised
AIV subtypes H5 and H7 respectively, of diverse geo-
graphic regions. Furthermore, we address the question
of steric hindrance of the N component by suggesting
doing a secondary ELISA test with another N type as
coating antigen. The ELISA proved to be more sensitive
than the HI test.
Materials and methods
Identity and preparation of antigen for development of
the ELISA
Several influenza A strains were used for production of
chicken sera for development of the ELISA test and for
HI test (Table 1): A/ostrich/Denmark/72429/96 (H5N2);
A/chicken/Belgium/150/99 (H5N2); A/mallard/Denmark/
64650/03 (H5N7); A/African starling/England/983/79
(H7N1); A/turkey/Ireland/95 (H7N7); A/mallard/
Denmark/64650G4/05 (H7N7); A/knot/England/SV497/
02 (H9N9); A/turkey/England/284/79 (H10N4); A/gull/
Denmark/48110/02 (H16N3) and A/swine/Denmark/
13608/04 (H1N2). Avian paramyxovirus (APMV)-8/
goose/Delaware/1053/76 was used to obtain AIV negative
control serum. Except for the Danish avian influenza
isolates [30,31] the strains were kindly supplied by the
EU Reference Laboratory for Avian Influenza AHVLA,
Weybridge, UK (EURL).
The virus was propagated by inoculation in the allan-
toic cavity of 8-10 days old specific pathogen free (SPF)
embryos (Lohmann Tierzucht, Cuxhaven, Germany).
Eggs were candled daily and allantoic fluid was har-
vested from dead embryos. The virus was inactivated
by addition of 1:1,200-2,000 β-propiolactone (Acros
Organics, Geel, Belgium) to the harvest. Inactivation
was confirmed by 3 blind passages in SPF eggs.
Production and characterisation of H5 and H7 mAb
The mAb specific for the H5 (Hyb 355-02) was pro-
duced by immunisation of female Balb/c mice with su-
crose purified H5N2 influenza virus A/chicken/Belgium/
150/99 (H5N2). All animal experiments were conducted
according to and approved by the Danish Animal Care
and Ethics Committee.
The mAb specific for the H7 (Hyb 351-01) was pro-
duced by immunisation of female Balb/c mice with
DNA plasmid (pCMV-HA) [32] (kindly provided by
Anses, Ploufragan-Plouzané Laboratory, France). The
H5 mAb was of IgG1 subtype and the H7 mAb was of
IgG subtype while characterised using Mouse MonoAB
ID kit (Zymed, California, USA) according to the manu-
factures protocol.
The specificity of the H5 and H7 mAbs was evaluated
by direct ELISA and immunocytochemistry using 44
AIV strains belonging to 24 AIV subtypes (Table 2). The
direct ELISAs to test for cross-reactivity of the H5 and
H7 mAb were performed with ELISA plates coated
with the different AIV antigens diluted according to
their HA titer: A/duck/Alberta/35/76 (H1N1), A/chicken/
Scotland/59 (H5N1), A/chicken/Belgium/150/99/ (H5N2),
A/turkey/Ireland/83 PD1744/83 (H5N8), A/turkey/
Ontario/7732/66 (H5N9), A/chicken/Netherlands/2992/
17/03 (H7N7), A/turkey/England/384/79 (H10N4). Subse-
quently, the plates were incubated with mAbs diluted and
subsequently processed as described for the inhibition
ELISA in this article. The immunocytochemistry was done
on chicken embryo fibroblast (CEF) infected with the dif-
ferent AIV strains (Table 2). The CEFs were fixed in 3%
formaldehyde in phosphate buffered saline (PBS) and the
immunocytochemistry was done as described previously
[33]. 3-Amino-9-Ethylcarbazole (AEC, DAKO Cytoma-
tion, Denmark) were used to visualise the reaction be-
tween infected cells and mAbs according to standard
procedures (DAKO Cytomation).
Sera
Experimentally produced polyclonal sera against H1, H5,
H7, H9, H10 and H16 were obtained by immunisation
of SPF chickens (Lohmann Tierzucht) with influenza A
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strains as listed in Table 1. In addition to the SPF chick-
ens, commercial broilers were immunised with A/ostrich/
Denmark/72429/96 (H5N2) and A/African starling/
England/983/79 (H7N1), respectively.
The birds (Table 1) were immunised at the age of 3, 5
and 7 weeks intramuscularly with 0.4 ml of β- propiolac-
tone inactivated allantoic fluid (H5 and H7) and incom-
plete Freunds adjuvant (DIFCO Laboratories, Detroit,
Michigan) in equal amounts. The birds immunised with
H1, H9, H10 and H16 were given live virus orally and into
the conjunctiva at the first immunisation and subsequently
immunised with inactive allantoic fluid with incomplete
Freunds adjuvant at the second and third immunisation.
Negative control sera from 14 SPF chickens were
tested by HI test for antibodies against H5 and H7 influ-
enza virus, Newcastle disease virus, Egg drop syndrome
virus and Infectious bronchitis virus with negative re-
sults. Additionally, sera from 13 SPF chickens
immunised with APMV-8/goose/Delaware/1053/76 were
used as negative controls.
HI test
The HI test of sera was performed according to the OIE
Manual [6] by use of a 2-fold sera dilution and 4 haem-
agglutination (HA) antigen units. Chicken red blood
cells (RBCs 1%, SPF chickens, Lohmann, Germany) were
used. The plates were incubated at 4°C for 30 minutes
and read after tilting of the plates. The HI titre was de-
termined as the value of the highest dilution of serum
causing complete inhibition of the 4 HA units of virus.
Titres < 16 were considered negative in accordance with
the OIE Manual [6]. All sera were tested by HI test with
a homologous inactivated virus. In addition a number of
sera of each subtype were tested against H5N2, H5N7,
H7N1 and H7N7 inactivated virus (data not shown).
Table 1 Avian influenza strains used for raising antibodies in chickens
Antigen Origin Animal Number of animals Age immunisation (weeks) Blood samples
weeks after 1. imm.
H5N2 VET SPF 15 3 1, 2, 3, 4, 6
A/ostrich/Denmark/72429/96
H5N2 VET Broiler 15 3 1, 2, 2½, 3, 6
A/ostrich/Denmark/72429/96
H5N2 EURL SPF 15 3, 5, 7 1, 2, 3, 4, 6
A/chicken/Belgium/150/99
H5N7 VET SPF 15 3, 5, 7 1, 2, 3, 4, 6
A/mallard/Denmark/64650/03
H7N1 EURL SPF 17 3, 5, 7 1, 2, 3, 4, 6
A/African starling/England/983/79
H7N1 EURL Broiler 10 3, 5, 7 1, 2, 3, 4, 6
A/African starling/England/983/79
H7N7 EURL* SPF 15 3, 5, 7 1, 2, 3, 4, 6
A/turkey/Ireland/95
H9N9 EURL* SPF 14 3, 5, 7 1, 2, 3, 4, 6
A/knot/England/02
H10N4 EURL SPF 16 3, 5, 7 1, 2, 3, 6
A/turkey/England/384/79
H16N3 VET SPF 12 4, 6, 8 1, 2, 3, 4, 5
A/gull/Denmark/7468110/02
PMV VET SPF 13 3, 5, 7 1, 3, 5
APMV-8/goose/Delaware/1053/76
H1N2 VET SPF 15 3, 5, 7 1, 2, 3, 4, 6
A/swine/Denmark/13608/04
*received inactivated and used directly.
imm. - immunisation.
VET- National Veterinary Institute, Technical University of Denmark.
EURL- EU Reference Laboratory for Avian Influenza, Virology Department, AHVLA Weybridge, UK.
SPF- Specific pathogen free.
Broiler- commercial broiler chickens.
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Inhibition ELISA
ELISA plates (MaxiSorp, Nunc, Denmark) were coa-
ted with allantoic fluid harvested from SPF eggs inocu-
lated with A/mallard/Denmark/64650/03 (H5N7) diluted
1:250 in PBS according to the HA titer of 1:256. Coated
plates were kept up to 14 days at 4°C. Before use, the
plates were washed 3 times (Skan Washer 300 version B,
Molecular Devices) with washing buffer (PBS with 0.05%
Tween 20). The test sera were diluted 1:10 in PBS con-
taining 1% bovine serum albumin (BSA) (A9647-100G,
Sigma, Denmark). A panel of positive and negative con-
trol sera was included in parallel on each plate and all
sera were tested in duplicate, 100 μl of diluted serum
were added to each of 2 wells and incubated for 1 hour
at room temperature (rt). Subsequently, the serum dilu-
tions were discharged by turning the plates up-side
down and 100 μl of the monoclonal antibody H5 mAb
Hyb 355-02 (0.025 μg/ml in PBS + 1% BSA) were added
to each well. After incubation for 1 hour at rt the plates
were washed as described above and 100 μl horse-radish-
peroxidase conjugated polyclonal rabbit anti-mouse IgG
(P0260, DakoCytomation, Glostrup, Denmark) diluted
1:1,000 in PBS + 1% BSA were added to each well. After
incubation for 1 hour at rt, the plates were washed as
described above and 100 μl of 1.2-phenylen-diamine-
dihydrochlorid (OPD, Kem-En-Tech Diagnostics A/S,
Denmark) were applied to each well. The colour de-
velopment was stopped by adding 100 μl of H2SO4
0.5 M. The optical density (OD) value of each test
well was read at 492 nm with a reference of 620 nm.
The percentage of inhibition (Inh%) was calculated in-
cluding the mean of the OD values of the sera tested
in duplicate (OD sample) and the mean of the max-
imum OD values for the negative control wells only
containing PBS (ODmax):
Inhibition %; Inh% ¼ ODmax−ODsample
ODmax
 100
Similarly, ELISA plates were coated with inactivated
A/African starling/England/983/79 (H7N1) diluted 1:300
in PBS and the procedure were as described above ex-
cept for the use of the monoclonal antibody H7 mAB
Hyb351-01 (0.025 μg/ml in PBS + 1% BSA).
Table 2 Pattern of reactivity of H5 and H7 mAb against
avian influenza viruses
Avian influenza isolates
used for IPX and ELISA*
Monoclonal antibodies
H5 H7
H7N1 A /duck/Taiwan/98 LP nd +
H7N1 A/chicken/Italy/99 LP nd +
H7N1 A/ostrich/South_Africa/91 LP nd +
H7N1 A/duck/Denmark/08 LP - +
H7N2 A/chicken/Wales/07 LP - +
H7N3 A/chicken/Pakistan/95 HP nd +
H7N3 A/chicken/Chile/02 HP - +
H7N3 A/chicken/British _Columbia/514/04 HP - +
H7N3 A/chicken/England/06 LP - +
H7N3 A/chicken/Saskatchewan/07 HP - +
H7N7 A/chicken/Netherlands/03 HP nd +
H7N7 A/turkey/Ireland/98 LP nd +
H7N7 A/turkey/England/08 HP - +
H5N1 A/turkey/Turkey/05 HP nd -
H5N2 A/chicken/France/03 LP nd -
H5N2 A/mallard/Denmark/06 LP + -
H5N2 A/mallard/Denmark/60347/06 LP nd -
H5N2 A/turkey/Italy/05 LP + -
H5N3 A/domestic duck/Italy/04 LP nd -
H5N9 A/chicken/Italy/97 LP + -
H1N1 A/turkey/Hungary/01 nd -
H2N3 A/mallard/England/06 nd -
H3N2 A/duck/Singapore/02 nd -
H4N6 A/duck/Denmark/02 nd -
H6N1 A/teal/7394/England/06 nd -
H6N2 A/teal/7440/England/06 nd -
H8N4 A/turkey/Ontario/68 nd -
H9N2 A/mallard/England/06 nd -
H9N2 A/chicken/Iran/99 nd -
H10N7 A/mallard/England/06 nd -
H10N7 A/chicken/England/01 nd -
H11N3 A/duck/Singapore/02 nd -
H13N6 A/herring gull/Finland/05 nd -
H14N6 A/mallard/Gurjev/91 nd -
H16N3 A/gull/Sweden/03 nd -
H1N1 A/duck/Alberta/35/76* - nd
H5N1 A/chicken/Scotland/59* + nd
H5N2 A/chicken/Belgium/150/99* + nd
H5N7 A/mallard/Denmark/75-64650/03* + nd
H5N8 A/turkey/Ireland/83* + nd
H5N9 A/turkey/Ontario/66* + nd
Table 2 Pattern of reactivity of H5 and H7 mAb against
avian influenza viruses (Continued)
H7N1 A/African starling/England/983/79* - +
H7N7 A/chicken/Netherlands/2992/17/03* - +
H10N4 A/turkey/England/384/79* - nd
IPX immunochemistry with immunoperoxidase test.
Uninfected CEFs were used as controls.
*tested by ELISA.
nd- not done.
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Subsequently, a number of sera of different AIV
subtypes were tested with H5N2 and H7N7 antigen to
eliminate steric hindrance of the N component (Tables 3
and 4). Thus a system with 2 subsequent ELISAs was
developed. First one ELISA with a specific antigen e.g.
H5N7 for screening was performed followed by a second
ELISA using another antigen e.g. H5N2 to exclude influ-
ence from steric hindrance of the N component. So for
each serum, the final result was expressed as the lowest
inhibition percentage given by ELISA.
All sera were tested twice in duplicate to test for re-
producibility. The second test was always performed
with a different batch of antigen coated ELISA plates
and at least 1 month since the first test and in most
cases also by different technicians.
Statistical analysis
Calculations of mean values, standard deviations and co-
efficients of linear regression were done as standard de-
scriptive procedures. For the 2-curve receiver operating
characteristic (ROC) true positive sera were defined as
those originating from the first blood sampling with a
homologous HI-titer ≥ 16 (either H5- or H7-specific de-
pending on the H5- or H7-based ELISA assessed re-
spectively). True negative sera were selected as the latest
blood sample of a heterologous infection provided a
HI-titer ≥ 16 was evident with the respective homolo-
gous H-protein. For example serum from a chicken in-
fected with H5N2 developed a HI titer ≥ 16 tested with
H5N2 antigen was used as negative serum in the calcu-
lations for the H7 ELISA.
Results
Specificity of the H5 and H7 mAbs
The H5 and H7 mAbs were specific as they recognised
only H5 and H7 subtype AIV strains shown by immuno-
cytochemistry and direct ELISA coated with various AIV
strains (Table 2).
Specificity and sensitivity of the H5 inhibition ELISA
For studies of specificity heterologous sera from chic-
kens immunised with PMV8, H16N3, H1N2, H9N9,
H10N4 and H7N1 were chosen. For each chicken the
final blood sample (5 or 6 weeks after immunisation,
Table 1) was selected, provided this sera was positive in
the HI-test (titer ≥16). When H5N7 inactivated virus
were used as coating antigen the majority of these heter-
ologous sera resulted in Inh% below 30. When H7N7
antisera were tested in the ELISA the results varied from
28 to 52 Inh%. With H5N2 virus as coating antigen low
responses (below 20 Inh%) were obtained for the same
sera, H1N2 sera yielding the highest mean response
(12.9 Inh%) (Table 3). Means and standard deviations for
the two assays and for 2 subsequent ELISAs, where the
minimum value for the two assays are used as the final
result are shown in Table 3. The Mean + 2 standard de-
viations for the 2 subsequent ELISA was 18.3 Inh%.
The first seropositive blood sample (based on HI test)
from each animal were used for identification of the op-
timal cut-off value. ROC-curves for variable cut-off ’s
were produced. Using a total of 127 sera (50 true po-
sitive and 77 true negative) the 2 subsequent ELISA
produced an almost perfect ROC-curve, with 98% sensi-
tivity and 100% specificity using a cut-off at 20 Inh%
(Figure 1A).
The sensitivity of the H5-ELISA was evaluated by
comparison with the results of the HI-test. Sera from
chickens immunised with H5N7 virus were tested using
H5N2 inactivated virus as coating antigen in the ELISA
and as antigen in the HI test. The H5N2 sera were also
tested by both tests using inactivated H5N7 virus. Sixty
sera taken at the time of immunisation (week 0) from
the H5N7- and H5N2-immunised chickens were all
below 20 Inh%. At weeks 1, 2 and 3 post immunisation
(p.i.) sera was collected from 41 chickens. Antibodies
against H5 in the serum samples were detected approxi-
mately 1 week earlier with ELISA as compared to HI test
(Table 5).
Sensitivity and specificity of the H7 inhibition ELISA
The H7 ELISA sensitivity compared to HI test was cal-
culated the same way as for H5 (Table 5). Also in this
case seroconversion was detected almost 1 week earlier
with ELISA than with HI test. For the H7-ELISA, the
Table 3 Results of testing of the heterologous sera in the H5 inhibition ELISAs
Immunisation PMV8 (n = 8) H16N3 (n = 10) H1N2 (n = 7) H9N9 (n = 7) H10N4 (n = 16) H7N1 (n = 20) H7N7 (n = 12)
H5N7ag-ELISA 6.3 (13.5) 21.5 (31.0) 19.7 (26.7) 19.1 (27.9) 13.3 (18.3) 17.6 (26.6) 42.3 (55.8)
16.2 (28.0)
H5N2ag-ELISA 8.4 (11.9) 11.3 (15.1) 12.9 (18.7) 7.4 (11.7) 2.8 (12.2) 3.6 (18.6) 3.0 (17.8)
6.0 (18.7)
2 subsequent ELISA 5.6 (12.5) 11.3 (15.1) 12.9 (18.7) 7.4 (11.7) 2.7 (11.3) 3.6 (18.6) 3.0 (17.8)
5.7 (18.3)
Values are given as mean inhibition percentages and mean + 2 standard deviations (in brackets). Two subsequent ELISA implies that the first ELISA is done using
the H5N7 antigen and then a secondary ELISA is performed with the H5N2 antigen. The minimum value for the two assays is used as the final result.
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results of ELISA with the heterologous sera are pre-
sented in Table 4. Using H7N1 inactivated virus as coat-
ing antigen in the ELISA resulted in the highest Inh%
(19.6) in the sera from the H10N4 immunised chickens.
In comparison coating with the inactivated H7N7 virus
resulted in highest Inh% (15.7) in sera from the group of
H5N7 immunised chickens. The Mean + 2 standard de-
viation of the 2 subsequent ELISA was 17.7 Inh%. Using
a total of 121 sera (32 true positive and 89 true negative)
the ROC-determination for the 2 subsequent ELISA
gave a sensitivity of 97% and a specificity of 100% using
a cut-off at 20 Inh% (Figure 1B).
Stability of the inhibition ELISA
The ELISA was very stable with a good correlation be-
tween repeated ELISA tests: Pearson correlation coeffi-
cients were r = 0.96 and r = 0.98 for the H5 inhibition
ELISA for sera sampled at week 1 and week 2 p.i., re-
spectively (Figure 2A). For the H7 inhibition ELISA,
the corresponding values were: r = 0.96 and r = 0.97
(Figure 2B). The coefficient of variation (standard de-
viation/mean) was higher for the sera sampled 1 week
p.i. (14.1%) compared to sera sampled 2 weeks p.i.
(7.6%). This was also the case for H7 inhibition ELISA,
the coefficient of variation was 25.0% 1 week p.i. and 6.6%
2 weeks p.i.
Discussion
The H5 and H7 mAbs developed in this study appeared
to have a high specificity when tested against a variety of
AIV strains in ELISA and by immune peroxidase test
(Table 2). For practical reasons it was not possible to test
all possible H5 and H7 subtypes but due to the high re-
activity of the H5 and H7 mAbs it is assumed that these
mAbs bind to conservative epitopes largely shared inside
strains of the H5 and H7 subtypes respectively. Mul-
tipurpose mAbs have many advantages in diagnostic
settings [12]. Since only AIV subtype H5 and H7 are re-
portable to the World Organization for Animal Health
(OIE) and consequently the AIV surveillance normally
targets two subtypes with the HI test [6], H5 and H7
mAbs were the focus of the present study.
The analysis for specificity revealed interference in the
ELISA test with the N protein of the inactivated virus
antigen used for coating of the ELISA plates (Tables 3
and 4). When sera raised against H7N7 virus were tested
with H5N7 virus as coating antigen the result was posi-
tive (Inh% > 20) while negative (Inh% <20, Table 3) with
H5N2 virus as coating antigen. H7N1 and H5N7 virus
was chosen as coating antigens because these antigens
gave the most optimal OD values when tested against
serial dilutions of the mAb. However, the differences in
OD values between the tested antigens were marginal
(data not shown) and hence the ELISA is applicable for
antibodies to different N-types of H5 and H7 subtype
AIVs. Besides, they are LPAI viruses and were readily
available. Whole inactivated virus was chosen as coating
antigens because it makes the ELISA applicable in la-
boratories with no access to sophisticated equipment
and reagents like recombinant antigens. Steric hindrance
most likely could be circumvented by the use of purified
or recombinant antigens for coating [23,25]. The prob-
lem with steric hindrance is known from the HI test as
well [24,34].
To omit the problem for practical applicability this
study suggests 2 subsequent ELISAs first using one
antigen as screening followed by a secondary antigen to
exclude influence from steric hindrance of the N compo-
nent (Tables 3 and 4). This is in parallel to the general
recommendations for AIV serological surveillance [6]. By
doing 2 subsequent ELISAs the specificity are increased
and the problem with interference of the N protein are
omitted for both the H5 and H7 ELISA. It is suggested,
based on the ROC curves (Figure 1) to define results in
the first ELISA of < 20 Inh% as negative and based on the
Inh% of the heterologous sera (Tables 3 and 4) an upper
limit of > e.g. 80 Inh% as positive. To define such a limited
window of re-testing would reduce the extra cost of per-
forming 2 subsequent ELISAs considerably.
The H5 ELISA was shown to be able to detect anti-
bodies one week earlier compared to the HI test (Table 5).
Table 4 Results of testing of the heterologous sera in the H7 inhibition ELISAs
Immunisation PMV8 (n = 7) H16N3 (n = 6) H1N2 (n = 11) H9N9 (n = 7) H10N4 (n = 13) H5N7 (n = 14) H5N2c (n = 11) H5N2o (n = 20)
H7N1ag-ELISA −6.6 (10.1) 10.3 (17.3) 12.8 (22.1) 12.0 (19.6) 19.6 (38.2) 12.1 (25.7) 5.2 (11.0) 13.5 (26.1)
11.3 (29.3)
H7N7ag-ELISA 0.6 (6.1) 6.8 (22.2) 3.3 (17.3) 13.0 (25.7) 1.1 (13.2) 15.7 (30.2) 3.1 (12.0) 1.7 (14.6)
4.4 (19.9)
2 subsequent
ELISA
−7.1 (7.6) 4.3 (14.7) 3.1 (16.2) 10.1 (18.1) 1.1 (13.2) 11.1 (24.0) 2.7 (10.7) 1.7 (14.4)
3.0 (17.7)
Values are given as mean inhibition percentages and mean + 2 standard deviations (in brackets). 2 subsequent ELISA implies that the first ELISA is done using the
H5N7 antigen and then a secondary ELISA is performed with the H5N2 antigen.
Jensen et al. Acta Veterinaria Scandinavica 2013, 55:84 Page 6 of 10
http://www.actavetscand.com/content/55/1/84
This indicates a superior sensitivity for the performance of
2 subsequent ELISAs in the early phase of an infection
with AIV H5. The same was observed with the H7 ELISA
(Table 5). The higher relative sensitivity of the ELISA
compared to HI test corresponds with the results of other
AIV ELISAs [13,15,16,19,35-38]. Hence, it should be con-
sidered to replace the more laborious HI test or at least as
initial screening in the surveillance [17,34].
Detailed analysis of the H5 and H7 mAbs used in two
subsequent inhibition ELISAs resulted in a specificity of
100% for both the H5 and H7 ELISAs (Figure 1). The
specificities were based on experimentally produced sera
raised in chickens to homologous antigen and a variety
of heterologous AIV antigens and a paramyxovirus
(Tables 3 and 4). This high specificity together with the
different AIV antigens used to raise the tested sera
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Figure 1 ROC curves for inhibition ELISAs. A) H5 ELISA and B) H7 ELISA. The lowest of the inhibition% (inh-%) given by each successive ELISA
using H5N7ag/H5N2ag for H5, H7N1ag/H7N7ag for H7, is taken into account, Sens: sensitivity, spec: specificity, their percentage is shown in y-axis.
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indicated that the estimates of specificity are reasonable
also for field applications. However, the presence of false
positives in field sera compared to experimental infec-
tions is difficult to predict, so this ELISA is a promising
candidate to be evaluated using field sera from different
avian species in comparison with HI test. Interestingly, it
was found in another work that the HI test was most ac-
curate in detecting antibodies of naturally compared to
experimentally infected poultry [34]. Variable sensitivi-
ties and specificities have been detected by others [25]
for field sera of turkeys, ducks and chicken by the use of
a recombinant H5 mAb. However, others presented high
sensitivities and specificities with the H5 mAb and partly
purified antigens for a variety of field and experimental
avian sera [8]. High sensitivities and specificities were
also detected in field samples from chickens by a H5
ELISA developed during an outbreak of LPAI H5 in
Taiwan [35]. Similar results were described for a H5
ELISA detecting H5 antibodies of wild ducks in Italy
[27]. A H7 ELISA based on recombinant H7 mAB and
inactivated antigen was shown to have higher sensitivity
and specificity with experimental and field sera for use
by multiple avian species compared to HI test [23]. Im-
portantly the present H5 and H7 ELISA showed a very
high degree of reproducibility (Figure 2).
Conclusions
The inhibition ELISAs based on the H5 and H7 mAb
developed in this study and a combination of two in-
activated AI antigen per subtype proved to have a high
sensitivity and specificity compared to HI test in expe-
rimental sera. Two AI antigens were necessary to cir-
cumvent interference with the N protein. These ELISAs
detected H5 and H7 antibodies earlier during experi-
mental infection compared to the HI test both when
performed once and as 2 subsequent ELISAs. Thus the
ELISAs may represent an alternative to HI test for
screening for AI H5 and H7 antibodies.
Table 5 Comparison of detection of seroconversion of H5
and H7 antibodies with ELISA and HI test
H5/H7 Number of animals ELISA HI
Week 0 60/42 0/3.1 0/0
Week 1 41/27 54/59 2.4/11
Week 2 41/27 88/78 39/63
Week 3 41/27 98/100 93/100
The percentage of chickens which seroconverted in H5-ELISA (cut-off = 20 Inh%)
and HI test (cut-off = 16), when sera were tested against heterologous N-antigen
(H5N7 sera tested by ELISA plates coated with inactivated H5N2 virus and
H5N2 sera tested by inactivated H5N7 antigen). After the slash are shown the
percentage of chickens which seroconverted in H7-ELISA (cut-off = 20 Inh%) and
HI test (cut-off = 16). Sera were tested in ELISA against heterologous N-antigen
(H7N1 sera tested by ELISA plates coated with inactivated H7N7 virus and H7N7
sera tested by inactivated H7N1 virus), while all sera in HI test were tested against
H7N1 inactivated virus.
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Figure 2 Correlation between repeated ELISA testing on different days. (A) H5N7 antigen and (B) and H7N1 antigen, Inh%: Inhibition%.
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